Verano Holdings EBITDA Margin 2021-2025 | VRNOF
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Verano Holdings (VRNOF) over the last 10 years. The current EBITDA margin for Verano Holdings as of March 31, 2025 is .
| Verano Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.87B | $0.23B | 26.53% |
| 2024-12-31 | $0.88B | $0.24B | 27.45% |
| 2024-09-30 | $0.90B | $0.25B | 28.32% |
| 2024-06-30 | $0.92B | $0.28B | 30.00% |
| 2024-03-31 | $0.93B | $0.28B | 29.72% |
| 2023-12-31 | $0.94B | $0.29B | 30.60% |
| 2023-09-30 | $0.93B | $0.28B | 29.88% |
| 2023-06-30 | $0.92B | $0.28B | 30.05% |
| 2023-03-31 | $0.91B | $0.24B | 26.63% |
| 2022-12-31 | $0.88B | $0.22B | 24.89% |
| 2022-09-30 | $0.87B | $0.21B | 24.39% |
| 2022-06-30 | $0.84B | $0.19B | 22.78% |
| 2022-03-31 | $0.82B | $0.18B | 22.25% |
| 2021-12-31 | $0.74B | $0.16B | 22.12% |
| 2021-09-30 | $0.60B | $0.13B | 22.00% |
| 2021-06-30 | $0.46B | $0.11B | 24.02% |
| 2021-03-31 | $0.31B | $0.11B | 34.64% |
| 2020-12-31 | $0.23B | $0.11B | 46.49% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.226B | $0.879B |
| Verano Holdings Corp. is a multi-state cannabis company. It produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano(TM), Avexia(TM), Encore(TM) and M?V(TM). Verano Holdings Corp. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.390B | 27.94 |
| Boston Scientific (BSX) | United States | $154.114B | 38.58 |
| Stryker (SYK) | United States | $145.370B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $128.999B | 0.00 |
| Medtronic (MDT) | Ireland | $107.400B | 15.23 |
| Haleon (HLN) | United Kingdom | $51.375B | 29.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.537B | 0.00 |
| ResMed (RMD) | United States | $35.781B | 26.88 |
| GE HealthCare Technologies (GEHC) | United States | $32.121B | 15.25 |
| Agilent Technologies (A) | United States | $31.661B | 20.57 |
| Terumo (TRUMY) | Japan | $27.316B | 35.48 |
| Insulet (PODD) | United States | $22.872B | 89.78 |
| Koninklijke Philips (PHG) | Netherlands | $21.440B | 15.41 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.026B | 11.58 |
| Baxter (BAX) | United States | $15.164B | 11.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.767B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.893B | 20.51 |
| Lantheus Holdings (LNTH) | United States | $5.336B | 13.46 |
| Prestige Consumer Healthcare (PBH) | United States | $4.224B | 18.87 |
| Perrigo (PRGO) | Ireland | $3.672B | 9.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.304B | 15.05 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.068B | 25.49 |
| GN Store Nord (GNNDY) | Denmark | $2.170B | 17.98 |
| QuidelOrtho (QDEL) | United States | $2.005B | 13.79 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.61 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Acuren (TIC) | United States | $1.297B | 0.00 |
| Neogen (NEOG) | United States | $1.235B | 15.81 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Green Thumb Industries (GTBIF) | United States | $1.143B | 25.71 |
| Kestra Medical Technologies (KMTS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.74 |
| BioLife Solutions (BLFS) | United States | $0.983B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 9.14 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Owens & Minor (OMI) | United States | $0.491B | 4.07 |
| Capricor Therapeutics (CAPR) | United States | $0.466B | 0.00 |
| Surmodics (SRDX) | United States | $0.421B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.61 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.10 |
| Cresco Labs (CRLBF) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.259B | 21.87 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.213B | 0.00 |
| Quanterix (QTRX) | United States | $0.204B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| Brainsway (BWAY) | Israel | $0.193B | 51.10 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.48 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.12 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.080B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.033B | 44.71 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |